Database and news
Peptides
Research peptides, clinic marketing, access and quality risk coverage
Peptide regulatory status tracker
Where each peptide stands with FDA: its 503A bulks-list status, any FDA-approved product, advisory committee votes and anti-doping status, with the source for every change.
- FDA-approved Heart & blood
Angiotensin II
Angiotensin II is a natural hormone that raises blood pressure. A synthetic form, Giapreza, is FDA-approved for shock. See how it works and what trials show.
- FDA-approved Heart & blood
Bivalirudin
Bivalirudin (Angiomax) is an FDA-approved peptide anticoagulant used during heart procedures. Learn how it works, when it is used, and what trials found.
- FDA-approved Heart & blood
Desirudin
Desirudin is a recombinant hirudin once used to prevent clots after hip surgery. Learn how it blocks thrombin and why it is no longer sold in the U.S.
- FDA-approved Heart & blood
Desmopressin
Desmopressin is a synthetic vasopressin analog approved by the FDA since 1978. Learn how it concentrates urine, its approved uses, and its main safety risk.
- FDA-approved Heart & blood
Echinocandins
Echinocandins are FDA-approved antifungal lipopeptides that block the fungal cell wall. Learn how caspofungin, micafungin, and anidulafungin work and are used.
- FDA-approved Heart & blood
Eptifibatide
Eptifibatide (Integrilin) is an intravenous peptide that blocks platelet clumping during heart attacks and stenting. Learn how it works and its bleeding risk.
- FDA-approved Heart & blood
Motixafortide
Aphexda
Motixafortide is an FDA-approved CXCR4-blocking peptide that moves stem cells into the blood for collection in multiple myeloma. Learn how it works.
- FDA-approved Heart & blood
Nesiritide
Nesiritide is a lab-made copy of the heart hormone BNP, approved for acute heart failure. See how it works, what trials found, and its side effects.
- FDA-approved Heart & blood
Pegcetacoplan
Pegcetacoplan is an FDA-approved peptide that blocks complement C3. Learn how Empaveli and Syfovre work, what each is approved for, and key safety points.
- FDA-approved Heart & blood
Vancomycin
Vancomycin is an FDA-approved antibiotic for serious Gram-positive infections, including MRSA and C. difficile. Learn how it works, its uses, and side effects.
- FDA-approved Heart & blood
Vasopressin
Vasopressin (Vasostrict) is an FDA-approved hormone used in intensive care to raise blood pressure. Learn how it works, its uses, and side effects.
| Peptide | Status | 503A bulks list | FDA-approved product | WADA |
|---|---|---|---|---|
| Angiotensin II | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Bivalirudin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Desirudin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Desmopressin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Echinocandins | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Eptifibatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Motixafortide Aphexda | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Nesiritide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pegcetacoplan | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Vancomycin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Vasopressin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
Source: FDA 503A bulks-list categories, PCAC meeting materials and the WADA Prohibited List
Status labels Not FDA-approved Research use only FDA-approved Investigational Compounded (503A)
What each label means
- Not FDA-approved
- No FDA approval for any use in humans.
- Research use only
- Sold as a "research chemical" not for human use. Not FDA-approved; FDA considers such products unapproved new drugs when marketed for human use.
- FDA-approved
- FDA has approved this drug or biologic as safe and effective for its labeled use.
- Investigational
- Being studied in clinical trials; not approved by FDA for any use.
- Compounded (503A)
- Prepared by a state-licensed 503A pharmacy for an individual patient prescription. Compounded drugs are not FDA-approved.
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Methodology
Data sources
What we include
- Peptides that are marketed to consumers through telehealth, compounding pharmacies or “research use only” sellers, or that FDA or its advisory committee has reviewed for the 503A bulks list.
- The 503A status is the one on FDA’s published lists on the “status as of” date; advisory committee votes are recorded as non-binding recommendations.
How we verify
- Every status change is dated and linked to the FDA page or meeting materials it comes from.
- Profiles are reviewed by a clinician or pharmacist on our medical review panel.
Known gaps
- 503B (outsourcing facility) status is recorded only when FDA has stated it.
- Advisory committee outcomes are sometimes reported before FDA posts minutes; those records say so.
- Human trial counts cover registered trials we reviewed, not every published study.
Update frequency: Checked at least weekly and whenever FDA updates its 503A lists or holds a PCAC meeting.
CSV columns (19)
-
profile_url - Peptide profile on this site.
-
name - Peptide name.
-
synonyms - Other names, separated by semicolons.
-
status_503a - 503A bulks-list status code.
-
status_503a_label - 503A bulks-list status in plain English.
-
status_503b - 503B (outsourcing facility) status, when known.
-
fda_approved - true when an FDA-approved drug product contains the peptide.
-
approved_product - The FDA-approved product, when there is one.
-
wada - World Anti-Doping Agency status (Prohibited, Not listed, Not assessed).
-
dea_schedule - DEA controlled-substance schedule, when assessed.
-
status_labels - Status Label codes shown on the page, separated by semicolons.
-
last_status_change - Date of the current 503A status (YYYY-MM-DD): the advisory committee vote, FDA listing or bulks-list effective date, by status.
-
status_source_url - FDA document for the current status.
-
status_as_of - Date we last verified the status.
-
human_trial_count - Registered human trials we reviewed on ClinicalTrials.gov.
-
trial_ids - ClinicalTrials.gov NCT numbers, separated by semicolons.
-
unii - FDA Unique Ingredient Identifier.
-
last_reviewed - Date of the last medical/editorial review (YYYY-MM-DD).
-
last_updated - When this record last changed (ISO 8601).
“Peptide regulatory status tracker.” Tele Launched (dataset). Updated Oct. 27, 2026. Accessed Nov. 7, 2026. https://telelaunched.com/peptides/